ENTRY       D02103                      Drug
NAME        Phenytoin sodium (USP);
            Phenytoin sodium for injection (JP18);
            Aleviatin (TN);
            Dilantin (TN)
PRODUCT
  GENERIC   DILANTIN (Parke-Davis Div of Pfizer)
            DILANTIN (REMEDYREPACK)
            EXTENDED PHENYTOIN SODIUM (A-S Medication Solutions)
            EXTENDED PHENYTOIN SODIUM (American Health Packaging)
            EXTENDED PHENYTOIN SODIUM (Amneal Pharmaceuticals LLC)
            EXTENDED PHENYTOIN SODIUM (Aphena Pharma Solutions - Tennessee)
            EXTENDED PHENYTOIN SODIUM (Aurobindo Pharma Limited)
            EXTENDED PHENYTOIN SODIUM (AvKARE)
            EXTENDED PHENYTOIN SODIUM (Cardinal Health 107)
            EXTENDED PHENYTOIN SODIUM (Major Pharmaceuticals)
            EXTENDED PHENYTOIN SODIUM (PD-Rx Pharmaceuticals)
            EXTENDED PHENYTOIN SODIUM (REMEDYREPACK)
            PHENYTEK (Mylan Pharmaceuticals)
            PHENYTOIN SODIUM (A-S Medication Solutions)
            PHENYTOIN SODIUM (A-S Medication Solutions)
            PHENYTOIN SODIUM (Acella Pharmaceuticals)
            PHENYTOIN SODIUM (Bryant Ranch Prepack)
            PHENYTOIN SODIUM (Bryant Ranch Prepack)
            PHENYTOIN SODIUM (Bryant Ranch Prepack)
            PHENYTOIN SODIUM (Bryant Ranch Prepack)
            PHENYTOIN SODIUM (Bryant Ranch Prepack)
            PHENYTOIN SODIUM (Clinical Solutions Wholesale)
            PHENYTOIN SODIUM (HF Acquisition Co LLC)
            PHENYTOIN SODIUM (HF Acquisition Co LLC)
            PHENYTOIN SODIUM (Henry Schein)
            PHENYTOIN SODIUM (Henry Schein)
            PHENYTOIN SODIUM (Hikma Pharmaceuticals USA)
            PHENYTOIN SODIUM (Hikma Pharmaceuticals USA)
            PHENYTOIN SODIUM (NCS HealthCare of KY)
            PHENYTOIN SODIUM (Proficient Rx LP)
            PHENYTOIN SODIUM (REMEDYREPACK)
            PHENYTOIN SODIUM (REMEDYREPACK)
            PHENYTOIN SODIUM (REMEDYREPACK)
            PHENYTOIN SODIUM (RPK Pharmaceuticals)
            PHENYTOIN SODIUM (RPK Pharmaceuticals)
            PHENYTOIN SODIUM (Sun Pharmaceutical Industries)
            PHENYTOIN SODIUM (Sun Pharmaceutical Industries)
            PHENYTOIN SODIUM (Taro Pharmaceuticals U.S.A.)
            PHENYTOIN SODIUM (Unichem Pharmaceuticals (USA))
FORMULA     C15H11N2O2. Na
EXACT_MASS  274.0718
MOL_WEIGHT  274.2498
CLASS       Neuropsychiatric agent
             DG03199  Antiepileptic agent
              DG02031  Hydantoin antiepileptic
            Metabolizing enzyme substrate
             DG01642  CYP2C9 substrate
             DG01639  CYP2C19 substrate
            Metabolizing enzyme inducer
             DG02891  CYP2B6 inducer
             DG02853  CYP3A/CYP3A4 inducer
            Transporter inducer
             DG01893  ABCB1 inducer
REMARK      Therapeutic category: 1132
            ATC code: N03AB02
            Chemical structure group: DG00846
            Product (DG00846): D00512<JP/US> D02103<JP/US>
EFFICACY    Antiepileptic
COMMENT     Hydantoin derivative
TARGET      SCN1A [HSA:6323] [KO:K04833]
            SCN2A [HSA:6326] [KO:K04834]
            SCN3A [HSA:6328] [KO:K04836]
            SCN4A [HSA:6329] [KO:K04837]
            SCN5A [HSA:6331] [KO:K04838]
            SCN8A [HSA:6334] [KO:K04840]
            SCN9A [HSA:6335] [KO:K04841]
            SCN10A [HSA:6336] [KO:K04842]
            SCN11A [HSA:11280] [KO:K04843]
  PATHWAY   hsa04728(6323)  Dopaminergic synapse
METABOLISM  Enzyme: CYP2C9 [HSA:1559]; CYP2C19 [HSA:1557]
INTERACTION CYP induction: CYP3A [HSA:1576 1577 1551], CYP2B6 [HSA:1555]
            Transporter induction: ABCB1 [HSA:5243]
STR_MAP     map07033  Anticonvulsants
            map07231  Sodium channel blocking drugs
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N03 ANTIEPILEPTICS
               N03A ANTIEPILEPTICS
                N03AB Hydantoin derivatives
                 N03AB02 Phenytoin
                  D02103  Phenytoin sodium (USP) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Anticonvulsants
              Sodium Channel Agents
               Phenytoin
                D02103  Phenytoin sodium (USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               113  Antiepileptics
                1132  Hydantoins
                 D02103  Phenytoin sodium (USP); Phenytoin sodium for injection (JP18)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG03199  Antiepileptic agent
               DG02031  Hydantoin antiepileptic
                DG00846  Phenytoin
                 D02103  Phenytoin sodium
             Metabolizing enzyme substrate
              DG01642  CYP2C9 substrate
               DG00846  Phenytoin
                D02103  Phenytoin sodium
              DG01639  CYP2C19 substrate
               DG00846  Phenytoin
                D02103  Phenytoin sodium
             Metabolizing enzyme inducer
              DG02891  CYP2B6 inducer
               DG00846  Phenytoin
                D02103  Phenytoin sodium
              DG02853  CYP3A/CYP3A4 inducer
               DG00846  Phenytoin
                D02103  Phenytoin sodium
             Transporter inducer
              DG01893  ABCB1 inducer
               DG00846  Phenytoin
                D02103  Phenytoin sodium
            Drug classes [BR:br08332]
             Neuropsychiatric agent
              DG03199  Antiepileptic agent
               D02103  Phenytoin sodium
            Target-based classification of drugs [BR:br08310]
             Ion channels
              Voltage-gated ion channels
               Sodium channels
                SCN1A
                 D02103  Phenytoin sodium (USP) &lt;JP/US&gt;
                SCN2A
                 D02103  Phenytoin sodium (USP) &lt;JP/US&gt;
                SCN3A
                 D02103  Phenytoin sodium (USP) &lt;JP/US&gt;
                SCN4A
                 D02103  Phenytoin sodium (USP) &lt;JP/US&gt;
                SCN5A
                 D02103  Phenytoin sodium (USP) &lt;JP/US&gt;
                SCN8A
                 D02103  Phenytoin sodium (USP) &lt;JP/US&gt;
                SCN9A
                 D02103  Phenytoin sodium (USP) &lt;JP/US&gt;
                SCN10A
                 D02103  Phenytoin sodium (USP) &lt;JP/US&gt;
                SCN11A
                 D02103  Phenytoin sodium (USP) &lt;JP/US&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D02103  Phenytoin sodium for injection
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D02103
             Drug transporters
              D02103
            Pharmacogenomic biomarkers [br08341.html]
             Polymorphisms and mutations affecting drug response
              D02103
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG03199  Antiepileptic agent
               DG02031  Hydantoin antiepileptic
                DG00846  Phenytoin
             Metabolizing enzyme substrate
              DG01642  CYP2C9 substrate
               DG00846  Phenytoin
              DG01639  CYP2C19 substrate
               DG00846  Phenytoin
             Metabolizing enzyme inducer
              DG02891  CYP2B6 inducer
               DG00846  Phenytoin
              DG02853  CYP3A/CYP3A4 inducer
               DG00846  Phenytoin
             Transporter inducer
              DG01893  ABCB1 inducer
               DG00846  Phenytoin
DBLINKS     CAS: 630-93-3
            PubChem: 7849164
            LigandBox: D02103
            NIKKAJI: J394.728I
ATOM        20
            1   Z   Na   16.6434  -17.9173 #+
            2   C1z C    14.9800  -21.4200
            3   N1x N    15.4700  -20.1600
            4   C2y C    14.3500  -19.3900
            5   N2x N    13.1600  -20.1600
            6   C5x C    13.6500  -21.4200
            7   O1a O    14.3500  -17.9200 #-
            8   O5x O    12.8100  -22.6100
            9   C8y C    16.3800  -21.4200
            10  C8x C    17.0800  -22.6800
            11  C8x C    18.5500  -22.6800
            12  C8x C    19.2500  -21.4900
            13  C8x C    18.4800  -20.2300
            14  C8x C    17.0800  -20.2300
            15  C8y C    14.9800  -22.8900
            16  C8x C    13.7900  -23.5200
            17  C8x C    13.7900  -24.9200
            18  C8x C    15.0500  -25.6900
            19  C8x C    16.2400  -24.9900
            20  C8x C    16.2400  -23.5900
BOND        21
            1     2   3 1
            2     3   4 1
            3     4   5 2
            4     5   6 1
            5     2   6 1
            6     4   7 1
            7     6   8 2
            8     2   9 1
            9     9  10 2
            10   10  11 1
            11   11  12 2
            12   12  13 1
            13   13  14 2
            14    9  14 1
            15    2  15 1
            16   15  16 2
            17   16  17 1
            18   17  18 2
            19   18  19 1
            20   19  20 2
            21   15  20 1
///
